We help to develop new chemistries for novel products and technologies, as well as helping to improve existing processes.

Here is a selection of our market areas:

Fine Chemicals: We are working with fine chemical companies to develop technologies based on their own raw material strengths, giving access to new markets. Such developments enable them to maximise the potential of their fixed assets.

Pharmaceutical development: We are helping to solve problems encountered in chemical process development for innovative drug companies.

Process improvement for existing technologies: We have an extensive back catalogue of processes we have developed which are usually better (or at least as good as) than those in use. We are able to demonstrate their pre-eminence with efficiency information (see our process portfolio for more details). IPR in these cases is vested in DCL

Generic pharmaceuticals: We supply technology to process intermediates using non-infringing processes to take advantage of emerging opportunities.

Emerging pharma (biotech): Our breadth of expertise, experience and focus on practical problem solving is finding a number of applications with companies who are at the sharp end of the research process.